Source: Health News Daily

Ellipse Technology: NuVasive To Expand Global Presence, Product Portfolio With Ellipse Buy

NuVasive says Ellipse's magnetically adjustable implant systems will open new global markets, particularly in the pediatric space, and complement its current portfolio. Analysts say the move is positive, but at least one observer believes that NuVasive might have paid too much for the deal.

Read full article ยป
Est. Annual Revenue
$25-100M
Est. Employees
250-500
Ed Roschak's photo - President & CEO of Ellipse Technology

President & CEO

Ed Roschak

CEO Approval Rating

68/100

Read more